Abbott Laboratories (NYSE:ABT)
| 104.52 Delayed Data As of Dec 08 |  +0.47 / +0.45%Today’s Change | 89.67 Today|||52-Week Range 115.83 | -4.80% Year-to-Date |
Latest ABT News | Press Releases
Today’s Trading
| Previous close | 104.05 |
| Today’s open | 104.12 |
| Day’s range | 104.12 - 104.85 |
| Volume | 3,426,782 |
| Average volume (3 months) | 5,377,451 |
| Market cap | $182.1B |
Data as of 4:00pm ET, 12/08/2023
Growth & Valuation
| Earnings growth (last year) | -0.71% |
| Earnings growth (this year) | -17.58% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | +1.34% |
| P/E ratio | 35.5 |
| Price/Sales | 4.44 |
| Price/Book | 4.97 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BSXBoston Scientific Co... | -0.10 | -0.18% |
| BDXBecton Dickinson and... | -1.18 | -0.51% |
| DXCMDexcom Inc | -1.92 | -1.61% |
| WSTWest Pharmaceutical ... | +1.06 | +0.31% |
Data as of 4:00pm ET, 12/08/2023
Financials
| Next reporting date | January 24, 2024 |
| EPS forecast (this quarter) | $1.20 |
| Annual revenue (last year) | $43.7B |
| Annual profit (last year) | $6.9B |
| Net profit margin | 15.82% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Abbott Park, Illinois |
Forecasts
